Why the study?
Aging is a major risk factor for heart disease and correlates with maladaptive alterations that contribute to declining cardiac function.
Key points are not available for this paper at this time.
Design
Review
Mitochondrial targets in cardiac aging remain hypothesis-generating; leaves open clinical translation pending interventional trials.
The process of aging strongly correlates with maladaptive architectural, mechanical, and biochemical alterations that contribute to the decline in cardiac function. Consequently, aging is a major risk factor for the development of heart disease, the leading cause of death in the developed world. In this review, we will summarize the classic and recently uncovered pathological changes within the aged heart with an emphasis on the mitochondria. Specifically, we describe the metabolic changes that occur in the aging heart as well as the loss of mitochondrial fitness and function and how these factors contribute to the decline in cardiomyocyte number. In addition, we highlight recent pharmacological, genetic, or behavioral therapeutic intervention advancements that may alleviate age-related cardiac decline.
No takes yet. Share an insight, caveat, or question.
Mendoza et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: